Data for version 2 of L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial

Hasan Entezari, Mohammad

Data for version 2 of L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial

Posted on 2017-06-16 - 13:41

Clinical data on the effect of L-arginine supplementation on cardiovascular risk factors in healthy men

Data were collected from 52 healthy male sports club members (aged 18-35) at the Isfahan University Medical Sciences, Ishfan Iran. This was a double blind randomized controlled study where the intervention group were given 2000 mg L-arginine per day and the placebo group were given 2000mg maltodextrin per day over 45 days (November-December 2013). Please see associated article for more detailed methods.

CITE THIS COLLECTION

DataCite

3 Biotech

3D Printing in Medicine

3D Research

3D-Printed Materials and Systems

4OR

AAPG Bulletin

AAPS Open

AAPS PharmSciTech

Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg

ABI Technik (German)

Academic Medicine

Academic Pediatrics

Academic Psychiatry

Academic Questions

Academy of Management Discoveries

Academy of Management Journal

Academy of Management Learning and Education

Academy of Management Perspectives

Academy of Management Proceedings

Academy of Management Review

Pahavani, Naseh; Jafari, Mostafa; Rezaei, Masoud; Rasad, Hamid; Sadeghi, Omid; Ali Rahdar, Hossein; et al. (2017). Data for version 2 of L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial. f1000research.com. Collection. https://doi.org/10.6084/m9.figshare.c.3804793.v1

https://doi.org/10.6084/m9.figshare.c.3804793.v1

or

Select your citation style and then place your mouse over the citation text to select it.